amifostine anhydrous and technetium tc 99m dimercaptosuccinic acid

amifostine anhydrous has been researched along with technetium tc 99m dimercaptosuccinic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altaner, S; Caloglu, M; Cermik, TF; Cosar-Alas, R; Kaldir, M; Kocak, Z; Parlar, S; Saynak, M; Tokatli, F; Türe, M; Uzal, C; Yurut-Caloglu, V1

Other Studies

1 other study(ies) available for amifostine anhydrous and technetium tc 99m dimercaptosuccinic acid

ArticleYear
Amifostine use in radiation-induced kidney damage. Preclinical evaluation with scintigraphic and histopathologic parameters.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2008, Volume: 184, Issue:7

    Topics: Amifostine; Animals; Female; Injections, Intraperitoneal; Kidney; Kidney Function Tests; Kidney Tubules; Premedication; Radiation Injuries; Radiation-Protective Agents; Radionuclide Imaging; Rats; Technetium Tc 99m Dimercaptosuccinic Acid

2008